[1]王 瑶,左 斌,阮长耿,等.免疫性血小板减少症中血小板生成与清除研究进展[J].现代检验医学杂志,2019,34(03):161-164.[doi:10.3969/j.issn.1671-7414.2019.03.042]
 WANG Yao,ZUO Bin,RUAN Chang-geng,et al.Recent Advances of Platelet Clearance and Thrombocytopoiesis in ITP[J].Journal of Modern Laboratory Medicine,2019,34(03):161-164.[doi:10.3969/j.issn.1671-7414.2019.03.042]
点击复制

免疫性血小板减少症中血小板生成与清除研究进展()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第34卷
期数:
2019年03期
页码:
161-164
栏目:
综述
出版日期:
2019-06-20

文章信息/Info

Title:
Recent Advances of Platelet Clearance and Thrombocytopoiesis in ITP
文章编号:
1671-7414(2019)03-161-04
作者:
王 瑶左 斌阮长耿何 杨
(江苏血液研究所 苏州大学附属第一医院,江苏苏州 215006)
Author(s):
WANG YaoZUO BinRUAN Chang-gengHE Yang
(Jiangsu Instituteof Hematology,the First Affiliated of Soochow University,Jiangsu Suzhou 215006,China)
关键词:
免疫性血小板减少症 血小板生成 血小板清除 进展
分类号:
R558.2
DOI:
10.3969/j.issn.1671-7414.2019.03.042
文献标志码:
A
摘要:
免疫性血小板减少症(immune thrombocytopenia,ITP)是机体对血小板抗原免疫失耐受,从而导致血小板生成受抑和破坏过度的一种获得性自身免疫性疾病,主要临床特征是血小板计数降低。血小板数量的维持与血小板生成和清除两方面机制有关。ITP中抗血小板自身抗体、CD8+ T细胞等多种免疫因素抑制血小板生成或介导血小板破坏,最终导致血小板数量减少。该文将对血小板生成与清除机制及其在ITP中的作用进行综述。
Abstract:
Immune thrombocytopenia(ITP)is an acquired autoimmune disease with the feature of impaired immune tolerance to platelet antigen,thereby leading to inhibition of platelet generation and excessive damage ofplatelets.Low platelet count is the main clinical manifestation of ITP.The mechanisms involved in platelet generation and clearance are considered as the maincontributors in the maintenance of platelet count.Platelet autoantibodies as well as multiple immune factors could either inhibit platelet generation or increase platelet destruction,ultimately resulting in a decrease in platelet count in ITP patients.The present paper will summary the mechanism involved in platelet generation and clearance and described its role in immune thrombocytopenia.

参考文献/References:

[1] PROVAN D,STASI R,NEWLAND A C,et al.International consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood,2010,115(2):168-186.
[2] LEFRANCAIS E,ORTIZ-MUNOZ G,CAUDRILLIER A,et al.The lung is a site ofplatelet biogenesis and a reservoir for haematopoietic progenitors[J].Nature,2017,544(7648):105-109.
[3] QUACH M E,CHEN Wenchun,LI Renhao.Mechanisms of platelet clearance andtranslation to improve platelet storage[J].Blood,2018,131(14):1512-1521.
[4] GROZOVSKY R,BEGONJA A J,LIU Kaifeng,et al.The ashwell-morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling[J].Nature Medicine,2015,21(1):47-54.
[5] XU Miao,LI June,NEVES M A,et al.GPIb alpha is required for platelet-mediated hepatic thrombopoietin generation[J].Blood,2018,132(6):622-634.
[6] MCMILLAN R,WANG Lei,TOMER A,et al.Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients[J].Blood,2004,103(4):1364-1369.
[7] IRAQI M,PERDOMO J,YAN Feng,et al.Immune thrombocytopenia:antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro[J].Haematologica,2015,100(5):623-632.
[8] YANG Lei,WANG Lin,ZHAO Chunhong,et al.Co-ntributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production inimmune thrombocytopenia[J].Blood,2010,116(20):4307-4316.
[9] NAZY I,KELTON J G,MOORE J C,et al.Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia[J].British Journal of Haematology,2018,181(2): 234-241.
[10] ZENG Dongfeng,CHEN Fang,WANG Song,et al.Autoantibody againstintegrin(αvβ3)contributes to thrombocytopenia by blocking the migration andadhesion of megakaryocytes[J].Journal of Thrombosis and Haemostasis,2018,16(9):1843-1856.
[11] QI Jiaqian,YOU Tao,PAN Tingting,et al.Downregulation of hypoxia-inducible factor-1 alpha contributes to impaired megakaryopoiesis in immune thrombocytopenia[J].Thrombosis and Haemostasis,2017,117(10):1875-1886.
[12] QUACH M E,DRAGOVICH M A,CHEN Wenchun,et al.Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets[J].Blood,2018,131(7):787-796.
[13] OLSSON B,ANDERSSON P O,JERNAS M,et al.T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura[J].Nature Medicine,2003,9(9):1123-1124.
[14] BOGGIO E,GIGLIOTTI C L,ROSSI D,et al.Decreased function of fas andvariations of the perforin gene in adult patients with primary immune thrombocytopenia[J].British Journal of Haematology,2017,176(2):258-267.
[15] QIU Jihua,SHAO Linlin,ZHOU Hai,et al.Platelet desialylation is closely associated with cytotoxic T lymphocyte-mediated platelet destruction in immune thrombocytopenia[J].Blood,2014,124(21):463.
[16] QIU Jihua,LIU Xuena,LI Xiaoqing,et al.CD8(+)T cells induce plateletclearance in the liver via platelet desialylation in immune thrombocytopenia[J].Sci Rep,2016,6:27445.
[17] DENG Gang,YU Shifang,LI Qiming,et al.Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia[J].Hematology,2017,22(3):155-161.
[18] GOETTE N P,GLEMBOTSKY A C,LEV P R,et al.Platelet apoptosis in adultimmune thrombocytopenia:insights into the mechanism of damage triggered by auto-antibodies[J].PLos One,2016,11(8):14.
[19] LEYTIN V,MYKHAYLOV S,STARKEY A F,et al.Intravenous immunoglobulininhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model ofimmune thrombocytopenia[J].British Journal of Haematology,2006,133(1):78-82.
[20] ZHAO Liang,LIU Jun,HE Chunyan,et al.Protein kinase A determines platelet life span and survival by regulating apoptosis[J].Journal of Clinical Investigation,2017,127(12):4338-4351.
[21] CHEN Mengxing,YAN Rong,ZHOU Kangxi,et al.Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia[J].Proc Natl Acad Sci USA,2018,115(45):E10682-E10691.

相似文献/References:

[1]李腾达,刘鹏,谷明莉,等.sCD93在免疫性血小板减少症患者中表达升高及临床意义[J].现代检验医学杂志,2016,31(06):115.[doi:10.3969/j.issn.1671-7414.2016.06.033]
 LI Teng-da,LIU Peng,GU Ming-li,et al.Higher Expression of Soluble CD93 in Patients with Immune Thrombocytopenia and Clinical Significance[J].Journal of Modern Laboratory Medicine,2016,31(03):115.[doi:10.3969/j.issn.1671-7414.2016.06.033]
[2]李腾达a,司 宇a,刘 鹏a,等.Gas6在免疫性血小板减少症患者中表达增高及临床意义[J].现代检验医学杂志,2017,32(03):37.[doi:10.3969/j.issn.1671-7414.2017.03.010]
 LI Teng-daa,SI Yua,LIU Penga,et al.Increased Expression of Gas6 in Patients with Immune Thrombocytopenia and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(03):37.[doi:10.3969/j.issn.1671-7414.2017.03.010]
[3]刘纯岳,方俊粤,林帝金,等.儿童免疫性血小板减少症患者外周血B淋巴细胞亚群变化的研究[J].现代检验医学杂志,2018,33(06):59.[doi:10.3969/j.issn.1671-7414.2018.06.015]
 LIU Chun-yue,FANG Jun-yue,LIN Di-jin,et al.B Lymphocyte Subsets in Peripheral Blood of Patients with Pediatric Immune Thrombocytopenia[J].Journal of Modern Laboratory Medicine,2018,33(03):59.[doi:10.3969/j.issn.1671-7414.2018.06.015]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81773356); 江苏省自然科学基金(BK20171204)。 作者简介:王 瑶(1995-),女,学士,在读硕士研究生,专业:血栓与止血,E-mail:20184232033@stu.suda.edu.cn。 通讯作者:何 杨,E-mail:heyang1963@163.com,Tel:0512-67781379。 收稿日期:2019-03-14 修回日期:2019-04-15
更新日期/Last Update: 2019-06-20